ES8304117A1 - "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina". - Google Patents

"un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".

Info

Publication number
ES8304117A1
ES8304117A1 ES512969A ES512969A ES8304117A1 ES 8304117 A1 ES8304117 A1 ES 8304117A1 ES 512969 A ES512969 A ES 512969A ES 512969 A ES512969 A ES 512969A ES 8304117 A1 ES8304117 A1 ES 8304117A1
Authority
ES
Spain
Prior art keywords
naftiridine
quinoleine
translation
compounds
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES512969A
Other languages
English (en)
Other versions
ES512969A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of ES512969A0 publication Critical patent/ES512969A0/es
Publication of ES8304117A1 publication Critical patent/ES8304117A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

UN PROCEDIMIENTO PARA PREPARAR SALES DE COMPUESTOS DE NAFTIRIDINA Y QUINOLEINA. SE HACE REACCIONAR UN COMPUESTO DE FORMULA GENERAL (I) CON UN ACIDO TAL COMO EL GALACTURONICO, ASPARTICO, GLUCONICO O EL GLUTAMICO. SE OBTIENE EL COMPUESTO (II) EN QUE X ES N O CH. ACTIVIDAD ANTIBACTERIANA.
ES512969A 1981-06-11 1982-06-09 "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina". Expired ES8304117A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27260181A 1981-06-11 1981-06-11
US33418281A 1981-12-24 1981-12-24

Publications (2)

Publication Number Publication Date
ES512969A0 ES512969A0 (es) 1983-02-16
ES8304117A1 true ES8304117A1 (es) 1983-02-16

Family

ID=26955624

Family Applications (1)

Application Number Title Priority Date Filing Date
ES512969A Expired ES8304117A1 (es) 1981-06-11 1982-06-09 "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".

Country Status (17)

Country Link
EP (1) EP0067666B1 (es)
KR (1) KR880002087B1 (es)
AU (1) AU551596B2 (es)
CA (1) CA1191842A (es)
DD (1) DD202561A5 (es)
DE (1) DE3267135D1 (es)
DK (1) DK155998C (es)
ES (1) ES8304117A1 (es)
FI (1) FI78292C (es)
GR (1) GR77194B (es)
HU (1) HU188181B (es)
IE (1) IE53259B1 (es)
IL (1) IL66027A (es)
NO (1) NO157739C (es)
NZ (1) NZ200908A (es)
PH (1) PH19091A (es)
SU (1) SU1192624A3 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3333719A1 (de) * 1983-09-17 1985-04-04 Bayer Ag Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
IT1196051B (it) * 1984-03-16 1988-11-10 Schiena Ricerche Composti ad attivita' antibatterica
DE3517709A1 (de) * 1985-01-05 1986-07-10 Bayer Ag Basische zubereitungen von chinoloncarbonsaeuren
US4657913A (en) * 1985-04-18 1987-04-14 Warner-Lambert Company Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents
HUT40429A (en) * 1985-04-29 1986-12-28 Chinoin Gyogyszer Es Vegyeszet Process for production of salts of derivatives of kynolin carbonic acid
DE3525335A1 (de) * 1985-07-16 1987-01-22 Bayer Ag Embonate von chinoloncarbonsaeuren und ihren derivaten
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
IT1196429B (it) * 1986-07-01 1988-11-16 Mediolanum Farmaceutici Srl Processo per la preparazione di pirido benzotiazine ad attivita' antibatterica e loro sali con acidi solfonici
IL80459A (en) * 1986-10-30 1991-04-15 Abic Ltd Water-soluble adduct of norfloxacin and nicotinic acid
JPH01175935A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd 凍結乾燥注射剤
US5188833A (en) * 1987-12-28 1993-02-23 Kyorin Seiyaku Kabushiki Kaisha Freeze-dried pharmaceutical preparations for parenteral use
US4948894A (en) * 1989-02-21 1990-08-14 American Cyanamid Company 8-fluoro and 7, 8, 10-trifluoro-9-(substituted)-6-oxo-6H-benzo-(C)quinolizine-5-carboxylic acids
KR0159540B1 (ko) * 1992-01-21 1998-12-01 김정순 퀴놀론-카복실산의 염 및 그 함유조성물
ES2127036B1 (es) * 1994-03-21 1999-11-16 Ind Quimica Agropecuaria S A Aducto de norfloxacina soluble en agua.
ES2088742B1 (es) * 1994-06-29 1997-03-16 Salvat Lab Sa Composicion antibiotica de aplicacion otica.
DE19500784A1 (de) * 1995-01-13 1996-07-18 Bayer Ag Enrofloxacin-Injektions- oder Infusionslösungen
MA24500A1 (fr) 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
WO2008127060A1 (en) 2007-04-13 2008-10-23 Dong Wha Pharmaceutical Co. Ltd. Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
ZA811304B (en) * 1980-03-11 1982-06-30 Warner Lambert Co Pharmaceutical salts of 4'-(9-acridinylamino)methanesulfon-m-anisidide

Also Published As

Publication number Publication date
NO157739C (no) 1988-05-11
SU1192624A3 (ru) 1985-11-15
HU188181B (en) 1986-03-28
KR840000544A (ko) 1984-02-25
DK155998C (da) 1989-11-06
AU8475782A (en) 1982-12-16
DK155998B (da) 1989-06-12
NO821931L (no) 1982-12-13
KR880002087B1 (ko) 1988-10-15
EP0067666A1 (en) 1982-12-22
ES512969A0 (es) 1983-02-16
DD202561A5 (de) 1983-09-21
FI822066A0 (fi) 1982-06-10
DK261582A (da) 1982-12-12
FI78292B (fi) 1989-03-31
CA1191842A (en) 1985-08-13
IL66027A0 (en) 1982-09-30
FI78292C (fi) 1989-07-10
IE53259B1 (en) 1988-09-28
DE3267135D1 (en) 1985-12-05
GR77194B (es) 1984-09-11
EP0067666B1 (en) 1985-10-30
IL66027A (en) 1986-02-28
IE821390L (en) 1982-12-11
PH19091A (en) 1985-12-19
AU551596B2 (en) 1986-05-08
NO157739B (no) 1988-02-01
NZ200908A (en) 1984-09-28

Similar Documents

Publication Publication Date Title
ES8304117A1 (es) "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
ES307300A1 (es) Procedimiento para la preparacion de nuevos 6,7-benzomorfanos sustituidos.
ES457993A1 (es) Un procedimiento para la preparacion de una isotiazolopiri- dina.
ES461979A1 (es) Un procedimiento para la preparacion de nuevos derivados delimidazol.
ES446187A1 (es) Un metodo de preparar nuevos compuestos de oxima-eter.
ES465346A1 (es) Procedimiento para preparar imidazoles 4,5-disustituidos.
ES462844A1 (es) Un procedimiento para la preparacion de compuestos imidazo (1,5-a) (1,4)diacepinicos.
ES465761A1 (es) Procedimiento para la obtencion de compuestos de acido 3-ha-logenosulfonil-tiofen-carboxilico.
ES457708A1 (es) Un procedimiento para la preparacion de un compuesto de 3- hidroximetil-2-cefem.
ES476405A1 (es) Un metodo para la preparacion de 2-metiltio-6-fluoro-9-(1- metil-4-piperilideno)-tioxanteno
ES438996A1 (es) Procedimiento para la obtencion de un derivado sustituido dedecano.
ES467734A1 (es) Procedimiento para la obtencion de derivados del 5-nitroimi-dazol.
ES8102568A1 (es) Metodo de preparar compuestos pirimidinicos con cabeza de puente de nitrogeno
ES402749A1 (es) Un procedimiento para la preparacion de derivados de tieno-diacepina.
ES449830A1 (es) Un procedimiento para la preparacion de compuestos de morfo-lina.
ES8302005A1 (es) Procedimiento para preparar compuestos cefalosporanicos
ES8100309A1 (es) Un procedimiento para la preparacion de 4-azo-5a-androstan-3-ona 17-sustituida.(como divisional de la patente numero 479.576)
ES468231A1 (es) Un metodo de preparar un compuesto complejo de una sal meta-lica con un compuesto de imidazol
ES435959A1 (es) Un procedimiento para obtener un derivado de pirido (3, 4-d)piridizina.
ES457688A1 (es) Nuevo procedimiento de obtencion de sales acidas de adicion de 3-fenil-5-dietilamino-etil-1,2-4,-oxodiazol.
ES382147A1 (es) Un procedimiento para preparar compuestos de morfolina n- sustituidos.
ES450204A1 (es) Un procedimiento para la preparacion de nuevos derivados delimidazol.
ES8107226A1 (es) Procedimiento para la preparacion de nuevas penicilinas
ES469554A1 (es) Procedimiento para la preparacion de 2-bromo-3-cloro-n-2- imidazolidinilidenbenzamina y de sus sales por adicion de acido.
ES8203879A1 (es) Procedimiento para preparar butirolactonas.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401